{"id":8772,"date":"2023-06-06T10:05:44","date_gmt":"2023-06-06T02:05:44","guid":{"rendered":"https:\/\/ttic.nhri.edu.tw\/?p=8772"},"modified":"2023-06-06T10:05:44","modified_gmt":"2023-06-06T02:05:44","slug":"2022%e5%b9%b4%e7%8d%b2%e8%ad%89%e5%b0%88%e5%88%a9%ef%bc%882022-issued%ef%bc%89-%e8%8b%b1","status":"publish","type":"post","link":"https:\/\/ttic.nhri.edu.tw\/en\/2022%e5%b9%b4%e7%8d%b2%e8%ad%89%e5%b0%88%e5%88%a9%ef%bc%882022-issued%ef%bc%89-%e8%8b%b1\/","title":{"rendered":"2022\u5e74\u7372\u8b49\u5c08\u5229\uff082022 Issued\uff09"},"content":{"rendered":"<table width=\"699\">\n<tbody>\n<tr>\n<td width=\"132\">Issue date<\/td>\n<td width=\"416\">Patent Title<\/td>\n<td width=\"151\">Patent No.<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/4<\/td>\n<td width=\"416\">Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine<\/td>\n<td width=\"151\">US11213495<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/5<\/td>\n<td width=\"416\">Opioid receptor modulators and use thereof<\/td>\n<td width=\"151\">MO J\/005174<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/5<\/td>\n<td width=\"416\">Heterocyclic compounds and use thereof<\/td>\n<td width=\"151\">MO J\/005468<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/5<\/td>\n<td width=\"416\">Heterodimeric Vascular Endothelia Growth Factor and Use Thereof<\/td>\n<td width=\"151\">EP3384029<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/7<\/td>\n<td width=\"416\">Heterocyclic compounds and use thereof<\/td>\n<td width=\"151\">HK1238644<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/1\/19<\/td>\n<td width=\"416\">Thiazolidinone compounds and use thereof<\/td>\n<td width=\"151\">J\/005474<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/2\/16<\/td>\n<td width=\"416\">Thiazolidinone compounds and use thereof<\/td>\n<td width=\"151\">KR10-2365673<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/1<\/td>\n<td width=\"416\">Method for calculating activity duration and efficiency<\/td>\n<td width=\"151\">TWI756992<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/1<\/td>\n<td width=\"416\">A vaccine against multiple mosquito-borne flavivirus and methods of preparing and using thereof<\/td>\n<td width=\"151\">TWI756812<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/1<\/td>\n<td width=\"416\">Serum succinate as cancer diagnostic biomarker and anti-succinate monoclonal antibodies for cancer treatment<\/td>\n<td width=\"151\">TWI756870<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/2<\/td>\n<td width=\"416\">Aminothiazole compounds and use thereof<\/td>\n<td width=\"151\">EP3411035<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/3<\/td>\n<td width=\"416\">Aminothiazole compounds as protein kinase inhibitors<\/td>\n<td width=\"151\">KR10-2372288<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/4<\/td>\n<td width=\"416\">Benzimidazole compounds and use thereof for treating alzheimer\u2019s disease or huntington\u2019s disease<\/td>\n<td width=\"151\">JP7035275<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/8<\/td>\n<td width=\"416\">Opioid receptor modulators and use thereof<\/td>\n<td width=\"151\">CA2996281<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/8<\/td>\n<td width=\"416\">Compositions and methods for enhancement of immune responses<\/td>\n<td width=\"151\">US11266728<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/11<\/td>\n<td width=\"416\">Heterocyclic compounds as kinase inhibitors for therapeutic uses<\/td>\n<td width=\"151\">TWI757722<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/16<\/td>\n<td width=\"416\">Cell culture device and electromagnetic stimulation cell culturing system having the same<\/td>\n<td width=\"151\">EP3715447<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/3\/29<\/td>\n<td width=\"416\">CpG-oligodeoxynucleotide, immunogenic composition comprising the same, and methods for preparing the composition and stimulating immune response thereby<\/td>\n<td width=\"151\">CN105530957<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/1<\/td>\n<td width=\"416\">Preparation of antivenom using recombinant toxins thereof<\/td>\n<td width=\"151\">TWI759750<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/5<\/td>\n<td width=\"416\">Primers, SNP markers and method for genotyping Mycobacterium tuberculosis<\/td>\n<td width=\"151\">US11293067<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/12<\/td>\n<td width=\"416\">Thiazole compounds as protein kinase inhibitors<\/td>\n<td width=\"151\">US11299489<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/13<\/td>\n<td width=\"416\">Dipicolylamine derivatives and their pharmaceutical uses<\/td>\n<td width=\"151\">KR102387835<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/22<\/td>\n<td width=\"416\">Heterodimeric vascular endothelial growth factor and use thereof<\/td>\n<td width=\"151\">CN108699562<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/4\/26<\/td>\n<td width=\"416\">A Microfluidic device for loading single cell in large microwells, and the using method threof<\/td>\n<td width=\"151\">CA2995474<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/5\/13<\/td>\n<td width=\"416\">CpG-oligodeoxynucleotide, immunogenic composition, and use thereof<\/td>\n<td width=\"151\">CN109593765<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/5\/20<\/td>\n<td width=\"416\">Thiazolidinone compounds and use thereof<\/td>\n<td width=\"151\">HK1258687<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/5\/23<\/td>\n<td width=\"416\">Aminothiazole compounds as protein kinase inhibitors<\/td>\n<td width=\"151\">RU2772645<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/5\/31<\/td>\n<td width=\"416\">Benzimidazole compounds and use thereof for treating Alzheimer\u2019s disease or Huntington\u2019s disease<\/td>\n<td width=\"151\">KR10-2405760<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/6\/11<\/td>\n<td width=\"416\">Cell strain having increased virus production ability and production method thereof<\/td>\n<td width=\"151\">TWI767433<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/6\/14<\/td>\n<td width=\"416\">AhR-ROR-\u03b3t complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease<\/td>\n<td width=\"151\">US11360080<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/6\/28<\/td>\n<td width=\"416\">Aminothiazole compounds and use thereof<\/td>\n<td width=\"151\">ZL201780010118.4<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/11<\/td>\n<td width=\"416\">Pyrimidine compounds and their pharmaceutical uses<\/td>\n<td width=\"151\">TWI770858<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/12<\/td>\n<td width=\"416\">Selective particles transfer from one device to another<\/td>\n<td width=\"151\">US11384326<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/15<\/td>\n<td width=\"416\">Aminothiazole compounds as protein kinase inhibitors<\/td>\n<td width=\"151\">MX393992<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/20<\/td>\n<td width=\"416\">Dipicolylamine derivatives and their pharmaceutical uses<\/td>\n<td width=\"151\">EP3145922<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/25<\/td>\n<td width=\"416\">Aminothiazole compounds as protein kinase inhibitors<\/td>\n<td width=\"151\">IN101988<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/7\/29<\/td>\n<td width=\"416\">Nanoemulsion adjuvant for nasal mucosa and preparation method thereof<\/td>\n<td width=\"151\">CN109718372<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/8\/10<\/td>\n<td width=\"416\">Method of Producing Exosomes from Stem Cells and Use Thereof<\/td>\n<td width=\"151\">GB2557696<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/8\/23<\/td>\n<td width=\"416\">Benzimidazole compounds and use thereof for treating alzheimer\u2019s disease or huntington\u2019s disease<\/td>\n<td width=\"151\">CN113613652<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/8\/30<\/td>\n<td width=\"416\">Thiazolidinone compounds and use thereof<\/td>\n<td width=\"151\">JP7132849<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/9\/26<\/td>\n<td width=\"416\">Sub-nanometer gold sticker and methods for protecting against endotoxin-induced sepsis thereof<\/td>\n<td width=\"151\">JP7146937<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/9\/27<\/td>\n<td width=\"416\">Aminothiazole compounds and use thereof<\/td>\n<td width=\"151\">KR10-2449712<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/10\/21<\/td>\n<td width=\"416\">Anti-human neurotensin receptor 1 antibody and use thereof<\/td>\n<td width=\"151\">TWI781647<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/10\/21<\/td>\n<td width=\"416\">Aminothiazole compounds and use thereof<\/td>\n<td width=\"151\">HK1258689<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/11\/11<\/td>\n<td width=\"416\">Methods for prediction, detection and monitoring of substance use disorders and\/or an infection<\/td>\n<td width=\"151\">TWI783453<\/td>\n<\/tr>\n<tr>\n<td width=\"132\">2022\/11\/22<\/td>\n<td width=\"416\">Opioid receptor modulators and use thereof<\/td>\n<td width=\"151\">JP7181536<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Issue date Patent Title Patent No. 2022\/1\/4 Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine US11213495 2022\/1\/5 Opioid receptor modulators and use thereof MO J\/005174 2022\/1\/5 Heterocyclic compounds and use thereof MO J\/005468 2022\/1\/5 Heterodimeric Vascular Endothelia Growth Factor and Use Thereof EP3384029 2022\/1\/7 Heterocyclic compounds and use thereof &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/ttic.nhri.edu.tw\/en\/2022%e5%b9%b4%e7%8d%b2%e8%ad%89%e5%b0%88%e5%88%a9%ef%bc%882022-issued%ef%bc%89-%e8%8b%b1\/\"> <span class=\"screen-reader-text\">2022\u5e74\u7372\u8b49\u5c08\u5229\uff082022 Issued\uff09<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[120],"tags":[],"table_tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/8772"}],"collection":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/comments?post=8772"}],"version-history":[{"count":1,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/8772\/revisions"}],"predecessor-version":[{"id":8777,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/8772\/revisions\/8777"}],"wp:attachment":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/media?parent=8772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/categories?post=8772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/tags?post=8772"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/table_tags?post=8772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}